Atlas Trials

The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal Cancer

Clinical trial NCT05628038 · RECRUITING

Trial details

NCT number
NCT05628038
Sponsor
Fudan University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Recurrent Rectal Cancer
Start date
2022-11-30
Primary completion
2024-12-01
Enrollment
93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.